Author

Li Li

ORCID 0000-0002-7785-9804Unclaimed ORCID profile · follow to get notified of new preprints

Additional preprints under this name without ORCID

Li Li18 papers · Shanghai Jiao Tong University

Biology Disciplines

Click to filter author papers

Genetic & Genomic Medicine· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1

Frequent Co-Authors

Amy Y. CheniD· 1 shared Austin T. GaoiD· 1 shared Bruce T. LahniD· 1 shared Chinnuwat SanguansermsriiD· 1 shared Cole K. ZhengiD· 1 shared Edi Setiawan TehuteruiD· 1 shared Hany Abueita· 1 shared Jack F. Hong· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperGenetic & Genomic Medicine

Amy Y. ChenORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Genetic & Genomic MedicinemedRxivPreprintApr 13, 2025

Safety and Efficacy of Vesemnogene Lantuparvovec, an AAV-Based Gene Therapy in Young Children Under 24 Months with Spinal Muscular Atrophy in Low- and-Middle- Income Countries. Second Interim Report (August 2025).

Lock Hock Ngu, Qingling Mo, Shiqi Li…·Austin T. Gao

This paper reports on a phase 1 trial of vesemnogene lantuparvovec, an affordable gene therapy for SMA, showing safety and improved motor milestones in young children.

1 citation

humanexperimental assay

𝕏 PostBluesky